No evidence of XMRV or MuLV sequences in prostate cancer, diffuse large B-cell lymphoma, or the UK blood donor population

Advances in Virology

Volumn 2011, Issue , 2011, Pages

  Robinson, Mark James ^a   Tuke, Philip William ^b   Erlwein, Otto ^a   Tettmar, Kate I ^b   Kaye, Steve ^a   Naresh, Kikkeri N ^c   Patel, Anup ^d   Walker, Marjorie M ^e   Kimura, Takahiro ^f   Gopalakrishnan, Ganesh ^g   Tedder, Richard S ^b,h   McClure, Myra O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Vedanayagam Hospital   (India)

^h PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE;

EID: 80755177096     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2011/782353     Document Type: Article

References (43)

1. Urisman A., Molinaro R. J., Fischer N., Plummer S. J., Casey G., Klein E. A., Malathi K., Magi-Galluzzi C., Tubbs R. R., Ganem D., Silverman R. H., silverr@ccf.org DeRisi J. L., joe@derisilab.ucsf.edu Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathogens 2006 2 3 211 225 10.1371/journal.ppat.0020025
2. Schlaberg R., Choe D. J., Brown K. R., Thaker H. M., Singh I. R., XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proceedings of the National Academy of Sciences of the United States of America 2009 106 38 16351 16356 2-s2.0-70349515582 10.1073/pnas.0906922106
3. Aloia A. L., Sfanos K. S., Isaacs W. B., Zheng Q., Maldarelli F., De Marzo A. M., ademarz@jhmi.edu Rein A., reina@mail.nih.gov XMRV: a new virus in prostate cancer? Cancer Research 2010 70 24 10028 10033 10.1158/0008-5472.CAN- 10-2837
4. Sabunciyan S., ssabunc1@jhmi.edu Mandelberg N., Rabkin C. S., Yolken R., Viscidi R., No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls. Molecular and Cellular Probes 2011 25 2-3 134 136 10.1016/j.mcp.2011.01.005
5. Fischer N., Hellwinkel O., Schulz C., Chun F. K. H., Huland H., Aepfelbacher M., Schlomm T., Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. Journal of Clinical Virology 2008 43 3 277 283 2-s2.0-53649090943 10.1016/j.jcv.2008.04.016
6. D'Arcy F. R., Foley A., Perry L., No evidence of XMRV in Irish prostate cancer patients with the R462Q mutations. European Urology 2008 7 supplement 271
7. Hohn O., Krause H., Barbarotto P., Niederstadt L., Beimforde N., Denner J., Miller K., Kurth R., Bannert N., Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009 6, article 92 2-s2.0-70450273189 10.1186/1742-4690-6-92
8. Danielson B. P., Ayala G. E., Kimata J. T., jkimata@bcm.tmc.edu Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. Journal of Infectious Diseases 2010 202 10 1470 1477 10.1086/656146
9. Lombardi V. C., Ruscetti F. W., Gupta J. D., Pfost M. A., Hagen K. S., Peterson D. L., Ruscetti S. K., Bagni R. K., Petrow-Sadowski C., Gold B., Dean M., Silverman R. H., Mikovits J. A., Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009 326 5952 585 589 2-s2.0-70350488874 10.1126/science.1179052
10. Mikovits J. A., judym@wpinstitute.org Lombardi V. C., Pfost M. A., Hagen K. S., Ruscetti F. W., Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence 2010 1 5 386 390 10.4161/viru.1.5.12486
11. Lo S.-C., shyhching.lo@FDA.hhs.gov Pripuzova N., Li B., Komaroff A. L., Hung G. -C., Wang R., Alter H. J., halter@mail.nih.gov Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proceedings of the National Academy of Sciences of the United States of America 2010 107 36 15874 15879 10.1073/pnas.1006901107
12. Erlwein O., o.erlwein@imperial.ac.uk Kaye S., Robinson M., McClure M., Chronic fatigue syndrome: xenotropic murine leukemia virus-related virus, murine leukemia virus, both, or neither? Proceedings of the National Academy of Sciences of the United States of America 2010 107 43 E161 10.1073/pnas. 1012441107
13. Switzer W. M., Jia H., Hohn O., Zheng H., Tang S., Shankar A., Bannert N., Simmons G., Hendry R. M., Falkenberg V. R., Reeves W. C., Heneine W., Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States. Retrovirology 2010 57, article 57 2-s2.0-77954059170 10.1186/1742-4690-7-57
14. Erlwein O., Kaye S., McClure M. O., Weber J., Wills G., Collier D., Wessely S., Cleare A., Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 2010 5 1 2-s2.0-77649137097 10.1371/journal.pone. 0008519 e8519
15. Groom H. C. T., Boucherit V. C., Makinson K., Randal E., Baptista S., Hagan S., Gow J. W., Mattes F. M., Breuer J., Kerr J. R., Stoye J. P., Bishop K. N., Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010 7, article no. 10 2-s2.0-77949477796 10.1186/1742-4690-7-10
16. Hong P., Pinghong98@yahoo.com Li J., ljm63hn@yahoo.com.cn Li Y., yongzhelipumc@yahoo.com.cn Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virology Journal 2010 7, article 224 10.1186/1743-422X-7-224
17. van Kuppeveld F. J., de Jong A. S., Lanke K. H., Verhaegh G. W., Melchers W. J., Swanink C. M., Bleijenberg G., Netea M. G., Galama J. M., van der Meer J. W., Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010 340 c1018 2-s2.0-77949495226 10.1136/bmj.c1018
18. Switzer W. M., bswitzer@cdc.gov Jia H., hjia@cdc.gov Hohn O., HohnO@rki.de Zheng H., hzheng@cdc.gov Tang S., stang@cdc.gov Shankar A., ashankar@cdc.gov Bannert N., BannertN@rki.de Simmons G., gsimmons@bloodsystems. org Hendry R. M., mhendry@cdc.gov Falkenberg V. R., vfalkenberg@cdc.gov Reeves W. C., wreeves@cdc.gov Heneine W., wheneine@cdc.gov Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States. Retrovirology 2010 7, article 57 10.1186/1742-4690-7-57
19. Henrich T. J., Li J. Z., Felsenstein D., Kotton C. N., Plenge R. M., Pereyra F., Marty F. M., Lin N. H., Grazioso P., Crochiere D. M., Eggers D., Kuritzkes D. R., Tsibris A. M.N., atsibris@partners.org Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. Journal of Infectious Diseases 2010 202 10 1478 1481 10.1086/657168
20. Flowers C. R., Barbara.Copeland@emoryhealthcare.org Sinha R., Vose J. M., Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer Journal for Clinicians 2010 60 6 393 408 10.3322/caac.20087
21. Fisher S. G., Fisher R. I., The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004 23 38 6524 6534 2-s2.0-4444226528 10.1038/sj.onc.1207843
22. Allory Y., Challine D., Haioun C., Copie-Bergman C., Delfau-Larue M. H., Boucher E., Charlotte F., Fabre M., Michel M., Gaulard P., Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. American Journal of Surgical Pathology 2001 25 7 865 874 2-s2.0-0034956756 10.1097/00000478-200107000-00004
23. Carbone A., Cesarman E., Spina M., Gloghini A., Schulz T. F., HIV-associated lymphomas and gamma-herpesviruses. Blood 2009 113 6 1213 1224 2-s2.0-60849090778 10.1182/blood-2008-09-180315
24. Wong H. H., Wang J., Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly. Leukemia and Lymphoma 2009 50 3 335 340 2-s2.0-67650892412 10.1080/10428190902725813
25. Carbone A., Gloghini A., Dotti G., EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 2008 13 5 577 585 2-s2.0-45749107592 10.1634/theoncologist.2008-0036
26. Thorley-Lawson D. A., Gross A., Persistence of the Epstien-Barr Virus and the origins of associated lymphomas. New England Journal of Medicine 2004 350 13 1328 1337 2-s2.0-1642334164 10.1056/NEJMra032015
27. Taylor G. P., Matsuoka M., Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005 24 39 6047 6057 2-s2.0-25444456426 10.1038/sj.onc.1208979
28. Robinson M. J., mark.robinson1@imperial.ac.uk Erlwein O. W., o.erlwein@imperial.ac.uk Kaye S., steve.kaye@imperial.ac.uk Weber J., j.weber@imperial.ac.uk Cingoz O., Oya.Cingoz@tufts.edu Patel A., anup.patel@imperial.ac.uk Walker M. M., mm.walker@imperial.ac.uk Kim W. -J., wjkim@chungbuk.ac.kr Uiprasertkul M., simup@mahidol.ac.th Coffin J. M., john.coffin@tufts.edu McClure M. O., m.mcclure@imperial.ac.uk Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 2010 7, article 108 10.1186/1742-4690-7-108
29. Oakes B., brendan.oakes@tufts.edu Tai A. K., albert.tai@tufts.edu Cingöz O., oya.cingoz@tufts.edu Henefield M. H., madeleine.henefield@tufts. edu Levine S., cfssuelev@earthlink.net Coffin J. M., john.coffin@tufts.edu Huber B. T., brigitte.huber@tufts.edu Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 2010 7, article 109 10.1186/1742-4690-7-109
30. Sato E., esato@virus.kyoto-u.ac.jp Furuta R. A., furuta@osaka.bc.jrc.or. jp Miyazawa T., takavet@goo.jp An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 2010 7, article 110 10.1186/1742-4690-7-110
31. Hué S., phanestephane.hue@ucl.ac.uk Gray E. R., e.gray@ucl.ac.uk Gall A., ag8@sanger.ac.uk Katzourakis A., a.katzourakis@gmail.com Tan C. P., cp.tan@ucl.ac.uk Houldcroft C. J., ch8@sanger.ac.uk McLaren S., Sm2@sanger.ac.uk Pillay D., d.pillay@ucl.ac.uk Futreal A., paf@sanger.ac.uk Garson J. A., j.garson@ucl.ac.uk Pybus O. G., oliver.pybus@zoo.ox.ac.uk Kellam P., pk5@sanger.ac.uk Towers G. J., g.towers@ucl.ac.uk Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010 7, article 111 10.1186/1742-4690-7-111
32. Dupressoir A., Heidmann T., Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice. Oncogene 1997 14 24 2951 2958 2-s2.0-0030803587 10.1038/sj.onc.1201148
33. McCormick A. L., Brown R. H., Cudkowicz M. E., Al-Chalabi A., Garson J. A., Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 2008 70 4 278 283 2-s2.0-38549107484 10.1212/01.wnl.0000297552.13219.b4
34. Ratti C., Budge G., g.budge@csl.gov.uk Ward L., Clover G., Rubies-Autonell C., Henry C., Detection and relative quantitation of Soil-borne cereal mosaic virus (SBCMV) and Polymyxa graminis in winter wheat using real-time PCR (TaqMan®). Journal of Virological Methods 2004 122 1 95 103 10.1016/j.jviromet.2004.08.013
35. Ferns R. B., Garson J. A., Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control. Journal of Virological Methods 2006 135 1 102 108 2-s2.0-33646589636 10.1016/j.jviromet.2006.02.005
36. Stoye J. P., jstoye@nimr.mrc.ac.uk Silverman R. H., silverr@ccf.org Boucher C. A., c.boucher@erasmusmc.nl Le Grice S. F. J., legrices@mail.nih.gov The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop. Retrovirology 2010 7, article 113 10.1186/1742-4690-7-113
37. Smith R. A., smithra@u.washington.edu Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology 2010 7, article 112 10.1186/1742-4690-7-112
38. Editorial, Cause for concern. Nature 2011 471 366
39. Menéndez-Arias L., lmenendez@cbm.uam.es Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome. Reviews in Medical Virology 2011 21 1 3 17 10.1002/rmv.673
40. Tuke P. W., Tettmar K. I., Tamuri A., Stoye J. P., Tedder R. S., PCR Master Mixes Harbour Murine DNA Sequences. Caveat Emptor! PLoS ONE 2011 6 5 e19953 10.1371/journal.pone.0019953
41. Garson J. A., j.garson@ucl.ac.uk Kellam P., pk5@sanger.ac.uk Towers G. J., g.towers@ucl.ac.uk Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 2011 8, article 13 10.1186/1742-4690-8-13
42. Cohen J., Retrovirology: more negative data for link between mouse virus and human disease. Science 2011 331 6022 1253 1254 10.1126/science.331.6022.1253
43. Weiss R. A., A cautionary tale of virus and disease. BMC Biology 2010 8, article 124